About the Event:
Dr. Ulf Hannelius will present advantages of interdisciplinary collaboration using tools from data sciences, artificial intelligence, and business administration, with a focus on developing new drugs that can offer solutions to complex health problems and making them available for use.
About the Speaker:
Ulf Hannelius earned his PhD in Molecular Biology from the Karolinska Institute in Stockholm where he also conducted his post-doctoral research in cancer genomics. He received an Executive MBA degree from Stockholm School of Economics. Dr. Hannelius has had experience in business development in the biotech and medtech industries prior to joining Diamyd Medical in 2015 where he has served as the CEO since 2016.
Language: English